Emflaza

Deflazacort tablets What kind of medication is this? Deflazacort is a corticosteroid that is prescribed to individuals who are at least 5 years old and have been diagnosed with Duchenne muscular dystrophy (DMD). Before I start using this medication, what should I discuss with my health care providers? People have a right to know if you suffer from any of the following conditions: Hypersensitivity to the medication deflazacort; Changes in the Function of the Endocrine System, Including Suppression of the Hypothalamic-Pituitary-Adrenal Axis, Cushing's Syndrome, and Hyperglycemia; and Immunosuppression and an Increased Risk of Infection Immunosuppression and an increased risk of infection include an increased risk of new infections, aggravation, dissemination, or reactivation of latent infections, all of which have the potential to be severe and even lethal; Alterations in the Function of the Cardiovascular and Renal Systems, including increased blood pressure and sodium, as well as a lower potassium level; gastrointestinal diseases; perforations in the gastrointestinal tract Behavioral and Emotional Disturbances, including Psychosis, Euphoria, Insomnia, Mood Swings, Personality Changes, and Severe Depression; Effects on Bones: Decreases in Bone Mineral Density Effects on the Skin: Severe Rashes Effects on the Brain: Cataracts, infections, and glaucoma are only some of the possible ophthalmic side effects. Patients who are on immunosuppressive dosages of corticosteroids should not be given live or live attenuated vaccines, according to recommendations for vaccination. What is the correct way to take this medication? Oral administration of roughly 0.9 milligrams per kilogram per day is the daily dosage that is suggested to be taken. After the medication has been used for more than a few days, taper off the dosage gradually. What other substances could react with this medication? Strong or moderate CYP3A4 inhibitors include the following: Provide one third of the indicated dosage and avoid using moderate or high CYP3A4 inducers as much as possible because they may diminish the effectiveness of the treatment. What possible negative reactions may I have to this medication? The most frequent side responses include an appearance similar to Cushing's syndrome, a rise in body weight and hunger, an infection of the upper respiratory tract, coughing, pollakiuria, hirsutism, central obesity, and nasopharyngitis.